SWKH
Undervalued by 162% based on the discounted cash flow analysis.
Market cap | $216.53 Million |
---|---|
Enterprise Value | $241.96 Million |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $1.25 |
Beta | 0.31 |
Outstanding Shares | 12,472,727 |
Avg 30 Day Volume | 5,008 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 13.63 |
---|---|
PEG | -16.74 |
Price to Sales | 5.87 |
Price to Book Ratio | 0.8 |
Enterprise Value to Revenue | 6.03 |
Enterprise Value to EBIT | 15.29 |
Enterprise Value to Net Income | 19 |
Total Debt to Enterprise | 0.13 |
Debt to Equity | 0.11 |
No data
No data
swk holdings corporation is focused on becoming a market leading innovator in healthcare finance by providing capital to a broad range of life science companies, institutions and inventors. swk’s primary focus is on monetizing cash flow ...